Form D Summary: Ar Pharma $750000 Fundraising. Rajah Menon Submitted Oct 5 Form D

Health Care Ar Pharma, Inc. - Rajah Menon

Ar Pharma Financing

Ar Pharma, Inc., Corporation just submitted form D announcing $750,000 debt financing. This is a new filing. Ar Pharma was able to finance itself with $410,000 so far. That is 54.67% of the offering. The total private offering amount was $750,000. This form was filed on 2016-10-05. The reason for the financing was: unspecified. The fundraising still has about $340,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Ar Pharma is based in Massachusetts. The company’s business is Other Health Care. The form D was submitted by Rajah Menon Chief Executive Officer. The company was incorporated in 2015. The filler’s address is: 300 West Cummings Park, Suite 390, Woburn, Ma, Massachusetts, 01801. Rajah Menon is the related person in the form and it has address: 300 West Cummings Park, Suite 390, Woburn, Ma, Massachusetts, 01801. Link to Ar Pharma Filing: 000168362616000001.

Analysis of Ar Pharma Offering

On average, firms in the Other Health Care sector, sell 68.60% of the total offering size. Ar Pharma sold 54.67% of the offering. The financing is still open. The average fundraising size for companies in the Other Health Care industry is $1.16 million. The offering was 64.66% smaller than the average of $1.16 million. Of course this should not be interpreted as negative. Firms raise funds for different needs and reasons. The minimum investment for this offering was set at $10000. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Ar Pharma Also

The Form D signed by Rajah Menon might help Ar Pharma, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment